Back to the main directory
Press Release
- AFARAK GROUP: TUOTANTORAPORTTI Q3 2023 by GlobeNewsWire
- BuzzFeed Studios And Acast Launch New Podcast, “I Know That’s Right” Presented By HuffPost by BusinessWire
- Bitget Outperforms Industry with Strong Proof of Reserves Ratio of 199% by EQS Group AG
- Nordea Bank Abp: Managers' transactions - Syrjä by EQS Group AG
- Arnarlax Ehf, Has Finalized Sustainable Linked Facility Agreement With a New EUR 100 Million Bank Facility by GlobeNewsWire
- Monarch Announces it Has Been Served With a Prior Notice of Exercice of a Hypothecary Right by GlobeNewsWire
- Nordea Bank Abp flagging notification: BlackRock Inc.'s shareholding decreases below threshold of five percent by EQS Group AG
- PodcastOne (PODC) Expands Slate of Original Programming, Acquires Exclusive Rights to Vigilante Podcast, Including IP for TV/ Film by GlobeNewsWire
- Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting by BusinessWire
- Sdiptech AB (publ) - Parts of the management in Sdiptech AB (publ) sell shares to cover tax debt by GlobeNewsWire
- Parandusteade: PRFoods auditeeritud konsolideeritud majandusaasta aruanne 2022/2023 by GlobeNewsWire
- Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023 by GlobeNewsWire
- Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting by GlobeNewsWire
- Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual Meeting by GlobeNewsWire
- Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting by GlobeNewsWire
- MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023 by GlobeNewsWire
- HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023 by GlobeNewsWire
- IN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting by GlobeNewsWire
- Medicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) by GlobeNewsWire
- Xilio Announces Initial Monotherapy Safety and Anti-Tumor Activity Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, in Late Line Patients with Advanced Solid Tumors by GlobeNewsWire
- HII’s Newport News Shipbuilding Continues Hiring Push with Community Events by GlobeNewsWire
- BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months by GlobeNewsWire
- Síminn hf. - Ákvörðun fjármálaeftirlitsnefndar by GlobeNewsWire
- PodcastOne (Nasdaq: PODC) to Announce Second Quarter Fiscal 2024 Financial Results and Host Investor Webcast on November 9, 2023 by GlobeNewsWire
- Innofactor Oyj: Omien osakkeiden hankinta 3.11.2023 by GlobeNewsWire